LIVE - IC-OS Working Group Webinar - Cardiac Amyloidosis: Cardiac Imaging Pearls - September 2021
The International Cardio-Oncology Society is a committed group of professionals throughout the world who are striving to protect the cardiovascular health of all patients who are undergoing cancer...
Read More
The International Cardio-Oncology Society is a committed group of professionals throughout the world who are striving to protect the cardiovascular health of all patients who are undergoing cancer therapy. By optimizing the cardiac status of patients with cancer before, during and after their treatment, we are collectively improving the overall outcomes including survival and quality of life. We aim to provide the latest scientific and clinical education and research for anyone treating patients with cancer in the hopes of enhancing cardiovascular protection.
Speakers
Ashutosh Wechalekar is Professor of Medicine and Haematology at University College London and Honorary Consultant...
Ashutosh Wechalekar is Professor of Medicine and Haematology at University College London and Honorary Consultant Haematologist at University College London Hospital/Royal Free Hospital, London, UK. His clinical and research is focused on amyloidosis with a particular interest in cardiac amyloidosis. He leads the AL program for UK. His is the director of the Jack O’Neil Amyloidosis laboratory which is focused on amyloid typing and genomics. He leads UK’s first dedicated amyloidosis treatment clinic at University College London Hospitals and is leading development of a UK National Amyloidosis Treatment Network. He leads AL amyloidosis treatment and research in the UK. His research interests including the development of better risk stratification of the disease, reducing early cardiac mortality in AL, imaging, clonal biology and new treatment strategies in AL amyloidosis. He leads on several national and international clinical trials in AL amyloidosis and myeloma at UCL and has published extensively in the respective areas.
Margot Davis is a cardiologist at Vancouver General Hospital and St. Paul’s Hospital, a Clinical Assistant Professor...
Margot Davis is a cardiologist at Vancouver General Hospital and St. Paul’s Hospital, a Clinical Assistant Professor at the University of British Columbia, and Director of the UBC Cardiology-Oncology Program. She attended medical school and completed her Internal Medicine residency and Cardiology fellowship at the University of British Columbia. She then completed fellowships in Advanced Heart Failure & Transplant Cardiology and Cardio-Oncology & Cardiac Amyloidosis at Stanford University School of Medicine. She obtained her Master of Science degree in clinical epidemiology at the Harvard School of Public Health. Dr. Davis is Co-Chair of the CCS/CHFS Position Statement on Cardiac Amyloidosis, a Primary Panel member of the CCS Cardio-Oncology Guidelines, and a Secondary Panel member of the CCS Heart Failure Guidelines. She is on the Executive Committee of the Canadian Heart Failure Society Board of Directors and she is Vice President of the Canadian Cardiac Oncology Network. Her research interests are focused on the prevention, diagnosis, and management of heart disease related to cancer therapy, cardiac amyloidosis, and advanced heart failure